Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -386.83 | -222.58 | -203.40 | -151.14 |
Depreciation/ Depletion | 12.51 | 11.77 | 10.16 | 10.92 |
Non- Cash Items | -23.43 | -4.78 | 6.51 | 38.72 |
Changesin Working Capital | -31.45 | 146.47 | -21.51 | -50.40 |
Cashfrom Operating Activities | -429.20 | -69.12 | -208.23 | -151.90 |
Capital Expenditures | -26.51 | -15.39 | -32.68 | -6.00 |
Other Investing Cash Flow Items Total | 418.04 | -532.89 | 3.51 | 7.56 |
Cashfrom Investing Activities | 391.53 | -548.28 | -29.17 | 1.56 |
Financing Cash Flow Items | -1.60 | -7.72 | -22.30 | -8.13 |
Issuance( Retirement)of Stock Net | 0.00 | 702.78 | 409.26 | - |
Issuance( Retirement)of Debt Net | 44.02 | -78.31 | -157.64 | 167.41 |
Cashfrom Financing Activities | 42.42 | 616.76 | 229.32 | 159.28 |
Net Changein Cash | 4.75 | -0.64 | -8.08 | 8.95 |
Cash Interest Paid | 1.60 | 7.72 | 14.22 | 8.13 |
Cash Taxes Paid | 4.11 | -5.37 | -4.54 | 2.52 |
Foreign Exchange Effects | - | 0.00 | 0.00 | 0.00 |
Sun Pharma Advanced Research Com Dividend Sun Pharma Advanced Research Com Bonus Sun Pharma Advanced Research Com News Sun Pharma Advanced Research Com AGM Sun Pharma Advanced Research Com Rights Sun Pharma Advanced Research Com Splits Sun Pharma Advanced Research Com Board Meetings Sun Pharma Advanced Research Com Key Metrics Sun Pharma Advanced Research Com Shareholdings Sun Pharma Advanced Research Com Profit Loss Sun Pharma Advanced Research Com Balance Sheet Sun Pharma Advanced Research Com Q1 Results Sun Pharma Advanced Research Com Q2 Results Sun Pharma Advanced Research Com Q3 Results Sun Pharma Advanced Research Com Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks